<p>A 65-year-old woman with type 1 diabetes mellitus underwent haemodialysis with end-stage renal failure due to diabetic nephropathy. The patient received sensor-augmented pump therapy with the predictive low glucose management system to prevent recurrent severe hypoglycaemia. Hypoglycaemia was infrequent when the sensor-augmented pump therapy with a predictive low-glucose management system was properly working. However, the patient suddenly died 3 months after starting the treatment.</p>

MediSage Case Discussions

Explore the case of a diabetic patient on haemodialysis who faced challenges with hypoglycaemia despite advanced pump therapy.

Managing Diabetes in End-Stage Renal Failure

Diabetes

Clinical case discussion shared for educational purposes and professional medical opinion.